Found 7 results
Filters: Author is Solomon, Melani [Clear All Filters]
Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme. J Control Release. 2020 ;324:181-193..
Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers. J Control Release. 2019 ;305:41-49..
Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance. Biomaterials. 2017 ;147:14-25..
Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice. Mol Ther. 2017 ..
Lysosomal Enzyme Replacement Therapies: Historical Development, Clinical Outcomes, and Future Perspectives. Adv Drug Deliv Rev. 2017 ..